View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Liberum Research Team
  • Liberum Research Team

LIBERUM: Morning Comment

Commodity redEYE, Smith & Nephew, Medica Group, Hotel Chocolat, Mining LOWdown, Market Highlights

Liberum Research Team
  • Liberum Research Team

LIBERUM: UK Small & Mid Cap Dispatches

Commodity redEYE, Medica Group, Hotel Chocolat, Mining LOWdown, SMID Market Highlights

Edward Thomason ... (+2)
  • Edward Thomason
  • Seb Jantet

LIBERUM: Medica Group PLC* - Recommended cash offer

Medica has reached an agreement with IK Partners on the terms of a recommended all-cash offer at 212p per share. The acquisition values Medica at £269m (fully diluted), a 32.5% premium to the closing price prior to the announcement. The offer is recommended by Medica’s board. At the time of the announcement, IK Partners has received irrevocable undertakings for c.20% of Medica’s share register. If approved, the deal is expected to become effective in Q2 2023.

Liberum Research Team
  • Liberum Research Team

LIBERUM: UK Small & Mid Cap Dispatches

Global Oil Gas and LNG, Inspired Plc - Initiation, Artisanal Spirits - Initiation, Softcat, Centamin, AG Barr, Team17, Medica Group, Shanta Gold, SMID Market Highlights

Liberum Research Team
  • Liberum Research Team

LIBERUM: Morning Comment

Global Oil Gas and LNG, Inspired Plc - Initiation, Artisanal Spirits - Initiation, Softcat, Centamin, AG Barr, Team17, Medica Group, Shanta Gold, Market Highlights

Edward Thomason ... (+2)
  • Edward Thomason
  • Seb Jantet

LIBERUM: Medica Group PLC* - Two deals and on track for FY’23

Medica’s prelims are in line with our expectations. Encouragingly 2023 has started well supported by new contract wins across the board and a recovery in Elective activity, and our expectations for the full year are unchanged. Good progress continues to be made increasing reporter capacity and Medica has completed two small and inexpensive bolt-on acquisitions post-period end to further strengthen this. We remain of the view that the current multiple of just under 10x FY23 EV/EBITDA looks undema...

Medica Group: 1 director

A director at Medica Group bought 59,900 shares at 125p and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...

John Savin PhD
  • John Savin PhD

Bouncing back from Covid-depressed levels

Medica is the UK leader in teleradiology. Teleradiology is the electronic transmission and remote assessment of radiological images, including CT, MRI and x-ray scans. Hospitals transmit these images through Medica's platform to a network of remote radiologists who, from their own home, review and

Ed Stacey
  • Ed Stacey

Medica Group - Expanding the growth opportunity

Medica Group is the UK market leader in teleradiology — the transmission, interpretation and reporting of radiological images, such as X-rays, magnetic resonance imaging (MRI) and computerised tomography (CT) scans, remotely from where the patient is imaged. This market has been growing strongly ac

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch